Navigation Links
Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
Date:12/4/2012

c type or that due to lupus erythematosus."  Questcor has also launched a pilot effort in rheumatology, as Acthar is approved for several rheumatology-related conditions including Dermatomyositis, Polymyositis, Lupus and Rheumatoid Arthritis. Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.    For more information about Questcor, please visit www.questcor.com.

Note: Except for the historical information contained herein, this press release contains forward-looking statements that have been made pursuant to the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "believes," "continue," "could," "estimates," "expects," "growth," "may," "plans," "potential," "should," "substantial" or "will" or the negative of such terms and other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the following:

  • Our reliance on Acthar for substantially all of our net sales and profits;
  • Research and development risks and our reliance on third-parties to conduct research and development and the ability of research and development to generate successful results;
  • Our ability to receive high reimbursement levels from third party payers;
  • Our ability to comply with federal and state regulations, including regulations relating to pharmaceutical sales and marketing practices;
  • The results of any pending or future litigation, investigations or claims, inclu
    '/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
2. Questcor to Report Second Quarter Results on July 24, 2012
3. Questcor Reports Second Quarter Financial Results
4. Questcor Pharmaceuticals to Present at Investor Conferences in September
5. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
6. Questcor Comments on Insurance Policy Bulletin
7. Questcor to Conduct Conference Call to Discuss Reimbursement Process
8. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
9. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
11. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... SAN FRANCISCO , Aug. 21, 2014 ... U.S. Food and Drug Administration (FDA) has ... to detect atrial fibrillation (AFib), the most ... analysis process (algorithm) instantly detects if patients ... recordings taken on the mobile phone based ...
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Bedrocan Cannabis ... three independent members to its Board of Directors, ... experience of the company, a leading licensed producer ... . Internationally, Bedrocan has 13 years, experience in ... in seven countries, including Canada. ...
Breaking Medicine Technology:AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3
... BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ -- Sinovac Biotech Ltd. (Nasdaq: ... products in China, announced today that it has been ... Prevention (Beijing CDC) as one of the five manufacturers ... Beijing. As part of the bidding process, ...
... 24 The National Community Pharmacists ... Jaeger as Executive Vice President and CEO, heralding ... the association,s recent accomplishments and lead it to ... of, independent community pharmacies and the patients they ...
Cached Medicine Technology:Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens 2Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens 3NCPA Announces Kathleen Jaeger as CEO 2
(Date:8/21/2014)... Home Care Assistance of Centennial , a ... has received the Certified – Trusted Provider distinction from ... commitment to client satisfaction. , “Our goal at Home ... the South Metro Denver area are receiving the best ... Care Assistance of Centennial. “Home Care Pulse not ...
(Date:8/21/2014)... health authorities need to ensure that experimental drugs to ... of randomized controlled trials, according to a new Viewpoint, ... August, 2014]. , Leading bioethicists Professor Ezekiel ... Dr Annette Rid, of King,s College London, UK, outline ... if experimental drugs are to be deployed in the ...
(Date:8/21/2014)... 2014 Dr. Vasili Gatsinaris, ... was recently recognized as one of the ... field of workers’ compensation. , The list ... Occupational Medicine Conference was created by polling ... case managers, disability specialists, physical therapists, rehabilitation ...
(Date:8/21/2014)... 21, 2014 According to a new ... Optics Market-Global Industry Analysis, Size, Share, Growth, Trends and ... market was valued at USD 863.1 million in 2013 ... 7.6% from 2013 to 2019, to reach an estimated ... medical fiber optics market is witnessing significant growth due ...
(Date:8/21/2014)... 21, 2014 The worlds of personal ... an exciting chance to grab free products. BaliniSports ... from Tom's of Maine with all qualifying purchases for ... our environmentally friendly yoga apparel is simply perfect,” said ... promotion between the two brands is intended to give ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 2Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 3Health News:The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials 2Health News:Dr. Vasili Gatsinaris Named One of the Top 50 Most Influential in Workers’ Compensation 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2
... 25 Videos Airing on Exclusive Statewide On-Demand Channel, ... the winner of the YouCare video contest. Rachel Sbrissa ... video that shares why,she chooses not to smoke. Sbrissa,s ... radiation for lung cancer when the,video was being created, ...
... Popular Series Begin Monday, July 14, on ... Television,s Home for Medical Mysteries -, SILVER SPRING, ... emergency room stories to television with,MYSTERY ER, the popular medical ... second season premieres 10 suspense-packed episodes,showcasing the life-threatening drama of ...
... - Company Expects to Submit Complete Response by ... 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) ... response from,the U.S. Food and Drug Administration (FDA) ... the Agency,s Approvable Letter for its once-daily,tramadol formulation ...
... insurance consulting service reports that "Republican candidate John ... to buying a computers or cars" saying competition ... care proposal of the presumptive Republican presidential nominee ... employer-sponsored system; it will make things worse, said ...
... autism spectrum disorder (ASD) frequently struggle to fit into a world ... find for adults than for children. SIMmersion LLC is hoping ... of its simulation software catered to practicing and strengthening communication skills. ... ...
... to reduce pain in newborns undergoing painful procedures ... (venipuncture) for the newborn screening test but not ... co-authors. , In this double-blind, randomized controlled ... Hospital, researchers found that "sucrose reduced overall pain ...
Cached Medicine News:Health News:Grandmother is Inspiration for Winner of Tobacco Free Florida YouCare Contest 2Health News:MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health 2Health News:MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health 3Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 2Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 3Health News:Florida Health Insurance Analyst says McCain's Group Health Ideas Bad for Employees 2Health News:Florida Health Insurance Analyst says McCain's Group Health Ideas Bad for Employees 3Health News:New Intervention for Adults with Autism Spectrum Disorder Prototype Completed by SIMmersion LLC 2Health News:New Intervention for Adults with Autism Spectrum Disorder Prototype Completed by SIMmersion LLC 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: